Patents by Inventor C. Kathleen DOREY

C. Kathleen DOREY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods for the treatment of pathological neovascularization in the eye
    Patent number: 9707304
    Abstract: The subject invention provides materials and methods useful in safely and effectively preventing pathological proliferation of blood vessels. The prevention of the over-proliferation of blood vessels according to the subject invention is particularly advantageous for treatment of certain ocular conditions including age-related macular degeneration (AMD), retinopathy of prematurity (ROP) and diabetic retinopathy. In preferred embodiments, the subject invention provides materials and methods for effective treatment of pathological ocular neovascularization using gene therapy. In a specific embodiment the materials and methods of the subject invention can be used to treat AMD.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: July 18, 2017
    Assignee: FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION
    Inventors: Janet C. Blanks, Howard M. Prentice, C. Kathleen Dorey
  • Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
    Publication number: 20160144056
    Abstract: The subject invention provides materials and methods useful in safely and effectively preventing pathological proliferation of blood vessels. The prevention of the over-proliferation of blood vessels according to the subject invention is particularly advantageous for treatment of certain ocular conditions including age-related macular degeneration (AMD), retinopathy of prematurity (ROP) and diabetic retinopathy. In preferred embodiments, the subject invention provides materials and methods for effective treatment of pathological ocular neovascularization using gene therapy. In a specific embodiment the materials and methods of the subject invention can be used to treat AMD.
    Type: Application
    Filed: December 15, 2015
    Publication date: May 26, 2016
    Inventors: Janet C. BLANKS, Howard M. PRENTICE, C. Kathleen DOREY
  • Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
    Publication number: 20150080458
    Abstract: The subject invention provides materials and methods useful in safely and effectively preventing pathological proliferation of blood vessels. The prevention of the over-proliferation of blood vessels according to the subject invention is particularly advantageous for treatment of certain ocular conditions including age-related macular degeneration (AMD), retinopathy of prematurity (ROP) and diabetic retinopathy. In preferred embodiments, the subject invention provides materials and methods for effective treatment of pathological ocular neovascularization using gene therapy. In a specific embodiment the materials and methods of the subject invention can be used to treat AMD.
    Type: Application
    Filed: July 18, 2014
    Publication date: March 19, 2015
    Applicant: FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION
    Inventors: Janet C. Blanks, Howard M. Prentice, C. Kathleen Dorey
  • Materials and methods for the treatment of pathological neovascularization in the eye
    Patent number: 8785413
    Abstract: The subject invention provides materials and methods useful in safely and effectively preventing pathological proliferation of blood vessels. The prevention of the over-proliferation of blood vessels according to the subject invention is particularly advantageous for treatment of certain ocular conditions including age-related macular degeneration (AMD), retinopathy of prematurity (ROP) and diabetic retinopathy. In preferred embodiments, the subject invention provides materials and methods for effective treatment of pathological ocular neovascularization using gene therapy. In a specific embodiment the materials and methods of the subject invention can be used to treat AMD.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: July 22, 2014
    Assignee: Florida Atlantic University Research Corporation
    Inventors: Janet C. Blanks, Howard M. Prentice, C. Kathleen Dorey
  • Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
    Publication number: 20120077870
    Abstract: The subject invention provides materials and methods useful in safely and effectively preventing pathological proliferation of blood vessels. The prevention of the over-proliferation of blood vessels according to the subject invention is particularly advantageous for treatment of certain ocular conditions including age-related macular degeneration (AMD), retinopathy of prematurity (ROP) and diabetic retinopathy. In preferred embodiments, the subject invention provides materials and methods for effective treatment of pathological ocular neovascularization using gene therapy. In a specific embodiment the materials and methods of the subject invention can be used to treat AMD.
    Type: Application
    Filed: September 27, 2011
    Publication date: March 29, 2012
    Inventors: Janet C. Blanks, Howard M. Prentice, C. Kathleen Dorey
  • GFAP-BASED GENE THERAPY FOR TREATMENT OF RETINAL DISEASES
    Publication number: 20080305083
    Abstract: Compositions and methods for reducing neovascularization. Purified nucleic acid constructs and vectors encoding an anti-angiogenic protein operably linked to a GFAP promoter. Vectors can include at least one hypoxia regulated element, enhancer element and silencer element. Gene therapy methods for reducing, delaying or preventing neovascularization based on the nucleic acid constructs and vectors.
    Type: Application
    Filed: April 17, 2008
    Publication date: December 11, 2008
    Applicant: FLORIDA ATLANTIC UNIVERSITY
    Inventors: C. Kathleen DOREY, Janet C. BLANKS, Howard PRENTICE